Literature DB >> 2335526

Identification and characterization of a mutation in the dihydrofolate reductase gene from the methotrexate-resistant Chinese hamster ovary cell line Pro-3 MtxRIII.

A P Dicker1, M Volkenandt, B I Schweitzer, D Banerjee, J R Bertino.   

Abstract

A methotrexate-resistant Chinese hamster ovary cell line (Pro-3 MtxRIII), resistant due to a low-level amplified, altered target enzyme, dihydrofolate reductase (DHFR), has been characterized on the molecular level. The cDNA and coding regions of all six DHFR exons were amplified in vitro using Taq polymerase and directly sequenced. Analysis of the Pro-3 MtxRIII DHFR cDNA demonstrated a C----T base transition at nucleotide 67 that results in the substitution of phenylalanine for leucine at residue 22 and the loss of a BsaI site in the Pro-3 MtxRIII cDNA. This mutation results in a decreased binding of methotrexate to the altered enzyme. Molecular modeling of Leu22----Phe supports the concept of the importance of Leu22 in the active site of the enzyme and indicates that replacement with phenylalanine will decrease the binding of methotrexate.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2335526

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-06-11       Impact factor: 16.971

2.  Isolation and characterization of a variant dihydrofolate reductase cDNA from methotrexate-resistant murine L5178Y cells.

Authors:  R S McIvor; C C Simonsen
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

3.  Isolation and characterization of a dihydrofolate reductase gene mutation in methotrexate-resistant Drosophila cells.

Authors:  H Hao; M G Tyshenko; V K Walker
Journal:  Gene Expr       Date:  1996

4.  Methotrexate resistance in an in vivo mouse tumor due to a non-active-site dihydrofolate reductase mutation.

Authors:  A P Dicker; M C Waltham; M Volkenandt; B I Schweitzer; G M Otter; F A Schmid; F M Sirotnak; J R Bertino
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

5.  In Silico Study Identified Methotrexate Analog as Potential Inhibitor of Drug Resistant Human Dihydrofolate Reductase for Cancer Therapeutics.

Authors:  Rabia Mukhtar Rana; Shailima Rampogu; Noman Bin Abid; Amir Zeb; Shraddha Parate; Gihwan Lee; Sanghwa Yoon; Yumi Kim; Donghwan Kim; Keun Woo Lee
Journal:  Molecules       Date:  2020-07-31       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.